"I would be very interested in hearing from you exactly what...

"I would be very interested in hearing from you exactly what route you have in mind for commercializing AOD-9604 outside the existing legal framework that would not involve the kind of risk I describe."

You may recall I suggested a non pharmaceutical trial involving post menapausal women (a huge market)to settle the question of efficacy with this group. You at the time said it wasn`t necessary for reasons I don`t recall. A well designed trial with the doses covered by the GRAS would settle the efficacy question in this group and provide a prospective partner under GRAS with efficacy in a specific group of the population. The trial will need to be done in some form and by someone because safety without efficacy will be a hard sell. Alas probably too late now without some cash(in short supply)and not much left in patent time.